AnPac Bio rises as H1 cancer test volumes more than double

Fresh2

20/07/2021 12:56

** Shares of China-based cancer test maker  ANPC.O  up 4.4%
at $4.19 premarket 
    ** Co says it has seen strong growth in test volumes in H1
of 2021
    ** Says total number of paid customers and testing volume
increased ~110% in H1 of 2021 vs same period in 2020 (https://refini.tv/3kHORoJ)
    ** In Q2, total paid tests and paid cancer tests rose ~280%
and ~270%, respectively over prior quarter
    ** Co expects strong test volume growth will continue
throughout this year
    ** Up to Monday's close, stock fell ~24% this year

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))